Forward P/S Multiple: Neuronetics (STIM)
Neuronetics, Inc. (STIM) generates revenue through the sale of magnetic brain stimulation devices. The forward P/S trend illustrates the impact of these sales on market capitalization, where 0.70 reflects the current value of this metric. Efficient equipment distribution to clinics supports margins, while expansion into private psychiatric networks helps the company overcome intense market pressure and broaden its presence.
Summary analytical data breakdowns for Neuronetics, Inc (STIM)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Neuronetics, Inc.|STIM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Neuronetics, Inc.|STIM - Company Aggregate Debts|Debt to Book Capitalization Ratio Neuronetics, Inc|STIM - Company Long-Term Debt|Company Current Liabilities Neuronetics|Quick Ratio neurostar.com
- financial results and valuation multiples details:
STIM - Company Net Income|Expected Profit Neuronetics, Inc.|STIM - Market Cap to Net Income Ratio|Projected Price to Earnings NeuroStar|STIM - PEG Multiple|EV/EBITDA Multiple Neuronetics, Inc|STIM - Operating income before deduction of amortization|Earnings per share for the last twelve months Neuronetics|STIM - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months neurostar.com|STIM - Net earnings per share growth this year|Earnings growth forecast for next year Neuronetics, Inc.
- sales and revenue indicators:
Fundamental company analysis:STIM (Neuronetics)
The forward P/S measures the ratio of the current market value of Neuronetics, Inc. (STIM) to its expected annual revenue, allowing for an assessment of the premium paid for future cash flows. By analyzing changes in the forward P/S, an investor can see how confidence in the unique TMS technology and the NeuroStar brand supports the capitalization of Neuronetics, Inc. (STIM) even amidst volatile demand for non-drug depression therapy.
Who Neuronetics, Inc. competes with
Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio Axogen (AXGN)|SI-BONE Inc (SIBN) - Projected Price to Revenue|Orthofix International - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bioventus Global BVS|OrthoPediatrics Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio treace.com TMCI|Strata Critical Medical (SRTA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CARL (Carlsmed, Inc.)|Price-to-Projected Revenue Ratio RxSight Corp|Forward Price-to-Revenue Multiple ClearPoint (CLPT)|Forward P/S Multiple STXS|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical International - Price to Expected Revenue Ratio|vivani.com (VANI) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue XTNT|NMTC (NeuroOne Medical Technologies Corporation) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Modular Med MODD|Forward Price-to-Revenue Multiple MYO (Myomo, Inc)|Forward P/S Multiple Envoy Medical Inc (COCH)|Price-to-Projected Revenue Ratio Vivos Therapeutics VVOS|Forward Price to Sales NVNO|SINT - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue AMIX|IVF (INVO Fertility Inc) - Forward P/S Multiple|Market Cap to Future Revenue Ratio bonebiologics.com BBLG|Forward Price-to-Revenue Multiple AXNX (Axonics)|Price to Expected Revenue Ratio BIOL|Forward P/S Multiple DYNT (Dynatronics)|Market Cap to Expected Sales Ratio Paragon 28 Inc. (FNA)|INVO Bio - Forward P/S Multiple
